International Journal of

Respiratory and Pulmonary MedicineISSN: 2378-3516

Archive

 Open Access DOI:10.23937/2378-3516/1410172

How Do Hospitalized Patients Tolerate Non-Invasive Positive Pressure Ventilation: A Pilot Patient-Centered Survey

Joanne Tsang, MD, Calvin H Hwang, MD, Kuhokee K Das, BS, Kathleen R Yan, BA, Paul J Christos, DrPH and Cynthia X Pan, MD

Article Type: Research Article | First Published: May 06, 2022

Non-invasive positive pressure ventilation (NIPPV) is increasingly used to treat in-patients with acute respiratory failure. NIPPV tolerability is often overlooked because it is usually thought of as a life-saving intervention. Studies examining patient tolerability of NIPPV are scarce and mostly qualitative. Our objective was to understand the hospitalized patient’s experiences and NIPPV tolerability. We conducted a pilot study using a novel NIPPV Tolerability Survey tool and conducted a cros...

 Open Access DOI:10.23937/2378-3516/1410171

Medical Chest Drain Insertion-Considerations for a Pleural Service

Ying Tung Liu, MBChB, FRACP, Zi Wei Goh, MBChB, FRACP and Lutz Beckert, MD, FRACP

Article Type: Research Article | First Published: April 11, 2022

To review local chest drain insertions, the indications, use of fibrinolytics, and the success rate of talc pleurodesis in a tertiary hospital in New Zealand. This is an observational study of all patients requiring chest drain insertion in the respiratory unit in Christchurch Hospital from January 2015 to December 2016. We analysed patient characteristics, type of drain inserted, and the nature of pleural fluid. We report the success of fibrinolytic therapy for empyema and pleurodesis for malig...

 Open Access DOI:10.23937/2378-3516/1410170

Free Testosterone Levels in Patients with Covid-19 and its Association with Disease Severity

Jesus Alan Guardado Vindiola, MD, Gisel Viviana Licon Martinez, MD, Marina Estrada-Rodriguez, Katya Lorena Wilhelmy-Ledesma, Joaquin Córdova Erberk, Álvaro Lozano Castañeda, Miguel Angel Gaxiola-García, MD, MSc and Hiram Javier Jaramillo-Ramírez, MD

Article Type: Research Article | First Published: April 11, 2022

The TMPRSS2 protein is an entry pathway for SARS-CoV-2, its expression is up-regulated by testosterone. Men have 7 to 8 times higher serum testosterone than women. We propose that patients hospitalized with COVID-19, with higher levels of testosterone, have worse outcomes than those with lower levels. A prospective, observational analysis of patients over 18-years-old with COVID-19 admitted to the internal medicine department in Mexicali’s General Hospital from January to April 2021. 49 patien...

Volume 9
Issue 2